Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Precision treatment in advanced hepatocellular carcinoma
2024 Standout
1 intermediate paper

Works of Ziwen Wei being referenced

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240
2021
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2020

Author Peers

Author Last Decade Papers Cites
Ziwen Wei 287 45 29 124 94 17 392
Shotaro Kato 285 23 27 131 50 13 405
Nicole Liscia 214 35 28 106 125 27 349
М. В. Копп 186 82 10 98 98 16 351
Shande Tang 150 35 39 95 134 15 442
Yiying Guo 247 17 60 78 148 26 404
Boyang Chang 222 68 38 91 139 25 446
Davide Bosso 128 28 24 162 128 18 348
Quanren Wang 304 30 9 163 75 25 421
Sarah E. Fenton 147 27 40 89 153 25 360
Clelia Donisi 204 32 37 94 141 26 357

All Works

Loading papers...

Rankless by CCL
2026